Smith & Nephew SNATS Inc Stock News

Smith & Nephew PLC (LSE:SN) said it expects its full-year results to come in at the low end of guidance, after the impact of the COVID-19 Delta variant and supply chain disruptions hit revenue in it

Smith & Nephew PLC shares represent a “rare value opportunity”, according to a leading investment bank that has reiterated its bullish stance on and price target for stock in the medical devices g

LONDON, Aug. 31, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will feature its recently expanded Extremities portfolio at the Americ

LONDON, Aug. 31, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase meaningful new material evidence for its OR3O Dual Mobil

LONDON, Aug. 30, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest Sports Medicine innovations for joint repair

LONDON, Aug. 30, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces its proprietary OXINIUM (Oxidized Zirconium) Technology has established

LONDON, Aug. 17, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of WEREWOLF FASTSEAL 6.0 Hemostasis Wand, bringing its leading

Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q2 2021 Results - Earnings Call Transcript

Smith & Nephew Plc (NYSE: SNN) revenues soared in Q2 as COVID-19 restrictions eased and levels of elective surgery returned towards normal in many markets. The Company reported revenues of $1.3 bil

Smith+Nephew's (SNN) FAST-FLIX FLEX Meniscal Repair System to provide long-term benefits to patients.

LONDON, July 7, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its FAST-FIX FLEX Meniscal Repair System, the only device

Smith & Nephew PLC's (LON:SN) growth drivers are “underappreciated” according to analysts at Credit Suisse, who have upgraded the stock to ‘outperform' from ‘neutral' and upped their target pr

LONDON, April 30, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, announces the publication of new research showing that clinicians estimated that 45% of

Smith & Nephew PLC (LON:SN.) reinstated full-year guidance as visibility is improving thanks to the COVID-19 vaccine rollout programmes and healthcare systems reopening to non-urgent surgery.

Smith & Nephew plc (SNN) CEO Roland Diggelmann on Q4 2020 Results - Earnings Call Transcript